FilingIndex
6-KThe Wire

YD Bio Ltd files 6-K

Filed Feb 26, 2026 · 5mo ago · Accession 0001213900-26-020678

Plain English

YD Bio Limited announced a strategic partnership between its subsidiary, YD Bio USA, Inc., and YC Biotech Co., Ltd. to create a "Taiwan-U.S. Dual-Core" regulatory platform for U.S. Food and Drug Administration (FDA) submissions. This partnership will involve YD Bio USA serving as YC Biotech's exclusive U.S. Agent and liaison with the FDA for its Asian Contract Research Organization clients.

Read the original on SEC.gov ↗
Filing details
Company
YD Bio Ltd
Ticker
YDES
CIK
2011674
Form type
6-K
Filing date
Feb 26, 2026
Report date
Feb 26, 2026
Document
ea0278346-6k_ydbio.htm
Size
31 KB